White powder Letrozole Femara For Anti-Breast Cancer 112809 51 5

Letrozole description:
Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.

Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.

Femara is used for the treatment of post-menopause breast cancer.

Letrozole (Steroids) basic info.
Femara Anti-Estrogen Powder Letrozole
Alias: Femara
CAS NO.: 112809-51-5
Molecular Formula: C17H11N5
Molecular Weight: 285.31
White or light yellow crystal
Method of Analysis: HPLC
Standard: USP/BP
Usage: Used as API in Treatment of breast disease.

Effect: letrozole in postmenopausal patients with advanced breast cancer whose Estrogen receptor and / or progesterone receptor positive or receptor status unknown
Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.

1. Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer.
2. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia.
3. It will also raise testosterone levels because of the lowered estrogen in the body.
4. Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women.
5. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.
6. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen.